Request PowerPoint
PowerPoint animations are preserved in the original file.
Slide index (67)
- Loading slide titles…
Loading presentation…
Slide text will appear here when the presentation loads.
Swipe on touchscreens · Use ← / → to change slides, Home / End to jump.
Lecture topics
- A disease of exposure and host immunity
- The lung is the usual portal of entry
- Two cytokine actions converge on phagocytes
- Extrapulmonary spread broadens the phenotype
- Coalescent lesions can consolidate lung tissue
- Narrow-based budding is a useful visual clue
- Antibody testing is another diagnostic route
- Selected primary reference
Slide index & full transcript (67 slides)
Text from the original slides, in presentation order. Diagrams and images remain in the viewer above.
Slide 1 · Histoplasmosis
An endemic dimorphic fungal infection
Environmental microconidia
Lung / phagocyte
Cell-mediated immunity
Lesion pattern
Dr Abu Suraih Sakhri
MBBS, MD (Pathology)
www.abusuraihsakhri.com
Slide 2 · Learning objectives
Explain the inhalational route and dimorphic fungal biology of Histoplasma capsulatum.
Trace macrophage survival, Th1 activation, and development of granulomatous inflammation.
Compare localized, chronic pulmonary, and disseminated disease.
Integrate morphology, tissue organisms, and diagnostic testing.
Slide 3 · A disease of exposure and host immunity
Environmental exposure
Pulmonary entry
Intracellular phase
Immune-dependent outcome
Mechanistic interpretation
Inhaled fungal microconidia initiate infection in the lung.
Histoplasma survives inside phagocytes before effective T-cell immunity develops.
Clinical outcomes range from self-limited lung lesions to disseminated infection.
Slide 4 · Histoplasma belongs to the endemic mycoses
The fungal-infection framework distinguishes endemic from opportunistic mycoses.
Endemic fungi are dimorphic and can cause serious systemic disease in otherwise healthy hosts.
Histoplasmosis can affect immunocompetent hosts but is more severe when cellular immunity is depressed.
Airborne microconidia
Slide 5 · Dimorphism links environment and tissue
The environmental phase is mold-like and produces inhalable conidia.
At human body temperature, the organism is encountered as yeast in tissue.
The infectious particle and the diagnostic tissue form are therefore different.
Environment: Mold + microconidia
Tissue: Budding yeasts
Schematic: Cell forms are not rendered at biological scale
Slide 6 · Microconidia are the infectious particles
The inhaled form is the small spore termed a microconidium.
Aerosolized spores are carried in dust rather than requiring direct contact with an infected person.
After pulmonary entry, the intracellular yeast phase becomes central to pathogenesis.
Airborne microconidia
Slide 7 · Contaminated soil is the environmental source
Contaminated soil
Dust disturbance
Airborne microconidia
Inhalation
Mechanistic interpretation
Soil contaminated with bird or bat droppings can harbor the organism.
Disruption of contaminated material can generate inhalable dust.
Environmental acquisition explains the exposure pattern; Disease begins after inhalation of spores.
Slide 8 · Exposure history can supply a diagnostic clue
Ask about contact with dust from soil associated with birds or bats.
Such exposure supports epidemiologic plausibility; It does not by itself prove infection.
Interpret any exposure history alongside clinical features and diagnostic studies.
Slide 9 · The Ohio and Mississippi valleys are core endemic regions
Ohio River Valley
Mississippi River Valley
Caribbean
The text identifies both river valleys as major endemic areas.
The Caribbean is also specifically identified as endemic.
Travel or residence in these regions helps frame the differential diagnosis.
Slide 10 · Histoplasma occurs beyond North America
Mexico, Central & South America
Parts of Europe & Africa
Eastern Asia & Australia
Other described regions include Mexico and Central and South America.
The text also lists parts of eastern and southern Europe, Africa, eastern Asia, and Australia.
Do not restrict histoplasmosis to one continent when interpreting clinical findings.
Slide 11 · The lung is the usual portal of entry
Inhalation
Lung
Macrophage uptake
Possible dissemination
Mechanistic interpretation
Pulmonary entry is described as virtually universal.
The earliest tissue interaction is between the inhaled organism and pulmonary phagocytes.
Subsequent extrapulmonary infection does not imply an extrapulmonary portal of entry.
Slide 12 · Histoplasma is an intracellular pathogen
The fungus is found mainly inside phagocytic cells.
This feature makes macrophage function a central determinant of disease control.
As with Mycobacterium tuberculosis, intracellular localization is central to host–pathogen interaction.
Mononuclear phagocyte
Cell nucleus
Intracellular yeasts
Schematic — not a photomicrograph
Slide 13 · Macrophage uptake is not sufficient for killing
Macrophages ingest the fungal organism.
Without T-cell help, these cells are unable to kill the ingested yeast effectively.
Phagocytosis and eradication must therefore be taught as separate events.
Ingested ≠ killed
Interpret with the full clinical and pathologic context
Slide 14 · The fungus can multiply in phagolysosomes
The pathogen survives and proliferates within the macrophage phagolysosome.
Its protected intracellular location permits amplification before acquired immunity matures.
This phase contributes to spread in the early course of infection.
Mononuclear phagocyte
Cell nucleus
Intracellular yeasts
Schematic — not a photomicrograph
Slide 15 · The early phase precedes effective T-cell immunity
Entry
Phagocyte survival
T-cell response (~10–14 d)
Control in competent host
Effective T-cell immunity develops approximately 10–14 days after infection.
Before that response, fungal multiplication and dissemination are possible.
The interval is a pathogenesis concept, not a fixed symptom-onset cutoff.
Slide 16 · Dissemination can precede immune containment
Primary lung focus
Macrophage-associated spread
T-cell response
Containment or progression
Mechanistic interpretation
The organism can leave the primary pulmonary focus during the early intracellular phase.
Dissemination and severe disseminated disease are not synonymous.
Later cell-mediated immunity determines whether fungal growth is contained.
Slide 17 · Th1 cells initiate effective intracellular control
Th1 helper T cells recognize fungal antigens.
They produce interferon-γ (IFN-γ) as a macrophage-activating signal.
This adaptive response converts an ineffective phagocyte into a better fungicidal effector.
Th1 cell
IFN-γ
Activated macrophage
Slide 18 · IFN-γ activates macrophage killing
Fungal antigen
Th1 lymphocyte
IFN-γ
Macrophage activation
Yeast killing
Mechanistic interpretation
IFN-γ is a key Th1-derived macrophage-activating cytokine.
Activated macrophages can kill intracellular yeast more effectively.
This explains the importance of intact cell-mediated rather than antibody-only immunity.
Slide 19 · TNF recruits additional macrophage effectors
Infected macrophage
TNF secretion
Macrophage recruitment
Fungal control
Mechanistic interpretation
Histoplasma induces macrophages to secrete tumor necrosis factor (TNF).
TNF recruits and stimulates other macrophages.
Cooperation among recruited phagocytes helps contain the infection.
Slide 20 · Two cytokine actions converge on phagocytes
Mediator
Cellular origin / action
Functional result
IFN-γ
Secreted by antigen-reactive Th1 cells
Macrophage activation
TNF
Secreted by macrophages; recruits macrophages
Amplified phagocyte response
Slide 21 · Cell-mediated immunity determines disease severity
Clinical / immunologic branches
Effective Th1 response
Macrophage activation
Granulomatous containment
Depressed T-cell response
Poor intracellular killing
Disseminated phagocyte-rich lesions
Slide 22 · Histoplasmosis has four major clinical patterns
Clinical / immunologic branches
Primary pulmonary
Chronic pulmonary
Extrapulmonary spread
Widely disseminated disease
Slide 23 · Primary pulmonary disease may resolve
Many infections are self-limited without progressive illness.
The initial lung focus may become clinically silent.
Resolution does not necessarily imply immediate disappearance of all visible tissue changes.
Slide 24 · Pulmonary infection may become latent
Primary pulmonary involvement can be followed by a clinically latent phase.
Fungal yeast forms can persist in tissue for years.
Persistent organisms and active progressive disease should not be conflated.
Persistence ≠ progression
Interpret with the full clinical and pathologic context
Slide 25 · A coin lesion may reflect a healed pulmonary focus
Histoplasma pulmonary lesions may appear as coin-shaped opacities on chest radiography.
Fibrosis and calcification can provide a structural explanation for a residual focal lesion.
Such imaging is not specific for histoplasmosis; Clinicopathologic correlation is needed.
Laminated residual focus
Schematic — not a photomicrograph
Slide 26 · Chronic pulmonary histoplasmosis favors the apices
Chronic progressive secondary lung disease is localized to the lung apices in the text.
A chronic apical abnormality therefore enters the differential with tuberculosis.
Distribution alone does not establish the causative organism.
Apical distribution (schematic)
Slide 27 · Chronic pulmonary symptoms mimic tuberculosis
Clinical feature
Histoplasmosis
Tuberculosis analogy
Cough
Described in chronic pulmonary disease
Can overlap
Fever
Described
Can overlap
Night sweats
Described
Can overlap
Apical involvement
Described
Can overlap
Slide 28 · Extrapulmonary spread broadens the phenotype
Lung entry
Extrapulmonary spread
Mediastinum
Adrenal glands
Liver
Meninges
Examples of extrapulmonary sites — not a frequency ranking
Slide 29 · Mediastinal involvement is a named site of spread
Extrapulmonary histoplasmosis can involve the mediastinum.
This is an anatomic extension of the pulmonary-centered differential.
Location alone cannot establish histoplasmosis without supporting evidence.
Anatomic spread
Interpret with the full clinical and pathologic context
Slide 30 · Adrenal and hepatic involvement indicate systemic spread
Lung entry
Extrapulmonary spread
Mediastinum
Adrenal glands
Liver
Meninges
Examples of extrapulmonary sites — not a frequency ranking
Slide 31 · Meningeal disease expands the clinical differential
The meninges are a recognized extrapulmonary target.
This location illustrates how an inhaled infection can later involve the central nervous system.
The meningeal location alone cannot identify the infecting organism.
Slide 32 · Dissemination is more severe with impaired immunity
Clinical / immunologic branches
Immunocompetent
Granuloma formation
Often self-limited
Immunosuppressed
Poor containment
Fulminant dissemination
Slide 33 · Two tissue responses are diagnostically important
Feature
Controlled lung disease
Fulminant dissemination
Inflammatory response
Granuloma formation
Granulomas may be absent
Tissue distribution
Localized lung foci
Multiple organs
Fungal location
May persist in lesions
Numerous yeasts in phagocytes
Slide 34 · Pulmonary lesions form granulomas
In otherwise healthy adults, the lung response is commonly granulomatous.
Granuloma formation reflects the organized cellular immune response to persistent microbes.
The response provides an anatomic substrate for later scarring and calcification.
Organized macrophage response
Schematic — not a photomicrograph
Slide 35 · Granulomas commonly become necrotic
Pulmonary Histoplasma granulomas frequently develop necrotic centers.
Necrosis contributes to the lesion’s similarity to tuberculous granulomas.
Necrosis is a pattern, not an organism-specific diagnosis.
Necrotic center
Schematic — not a photomicrograph
Slide 36 · Coalescent lesions can consolidate lung tissue
Multiple granulomas
Coalescence
Larger necrotic focus
Consolidation
Mechanistic interpretation
Adjacent necrotizing granulomas may merge.
The merging of foci can produce larger areas of pulmonary consolidation.
Thus, microscopic granulomas can correspond to a macroscopic parenchymal opacity.
Slide 37 · Healing produces fibrosis
Active focus
Inflammation resolves
Fibrosis
Residual scar
Spontaneous resolution or effective therapy can lead to fibrotic remodeling.
Fibrosis replaces the active inflammatory lesion with organized connective tissue.
A healed scar can remain visible long after the clinical episode.
Slide 38 · Concentric calcification produces a laminated lesion
Resolved lesions may undergo concentric “tree-bark” calcification.
The lamellar pattern is associated with resolved pulmonary lesions.
A calcified nodule records the prior tissue response; It does not establish current fungal activity.
Concentric calcification
Schematic — not a photomicrograph
Slide 39 · Persistent yeast and inactive-looking lesions can coexist
Observation
What it supports
What it does not prove
Yeasts seen in tissue
Histoplasma-compatible organism
Clinical progression by itself
Fibrotic or calcified focus
Previous tissue injury/healing
Ongoing active infection by itself
Slide 40 · Fulminant disease may lack organized granulomas
In immunosuppressed hosts, organized granulomatous inflammation may not develop.
Instead, focal collections of mononuclear phagocytes occur in tissues.
Failure to see granulomas must not exclude disseminated histoplasmosis.
Mononuclear phagocyte
Cell nucleus
Intracellular yeasts
Schematic — not a photomicrograph
Slide 41 · Yeast-filled phagocytes characterize dissemination
Macrophages and other mononuclear phagocytes can contain numerous fungi.
This cellular pattern may occur in tissues throughout the body.
Identification of organisms within cells is particularly useful when granulomas are absent.
Mononuclear phagocyte
Cell nucleus
Intracellular yeasts
Schematic — not a photomicrograph
Slide 42 · Peripheral blood may reveal infected monocytes
In disseminated disease, yeast may be identified in circulating monocytes.
A peripheral blood film can therefore occasionally provide direct morphological evidence.
A negative blood film does not exclude disseminated disease.
Mononuclear phagocyte
Cell nucleus
Intracellular yeasts
Schematic — not a photomicrograph
Slide 43 · Histoplasma yeasts are small and thin-walled
Tissue forms are described as small, thin-walled yeast cells.
Pear-shaped cells with thin-based budding are described in the representative tissue morphology.
Recognition depends on fungal morphology and localization, not size alone.
Thin-walled, budding yeast schematic
Schematic — not a photomicrograph
Slide 44 · Narrow-based budding is a useful visual clue
Pear-shaped yeasts with thin-based budding are a characteristic tissue clue.
The budding relationship is supportive but should not substitute for full tissue assessment.
Schematic forms illustrate the relationship; They are not photomicrographs.
Thin-walled, budding yeast schematic
Schematic — not a photomicrograph
Slide 45 · Granulomatous inflammation has a broad differential
Clinical / immunologic branches
Tuberculosis
Sarcoidosis
Coccidioidomycosis
Other granulomatous conditions
Slide 46 · Histoplasmosis and tuberculosis can closely resemble each other
Parameter
Histoplasmosis
Tuberculosis
Chronic apical disease
Can occur
Can occur
Necrotizing granulomas
Common in healthy hosts
Characteristic pattern
Disease-specific evidence
Intracellular fungal yeast
Evidence of mycobacteria
Slide 47 · Sarcoidosis is a noninfectious granulomatous mimic
Finding
Histoplasmosis
Sarcoidosis
Etiology
Histoplasma infection
Uncertain; noninfectious classification
Pulmonary granulomas
Often necrotic
Usually nonnecrotizing
Fungal organisms
May be identifiable
Not expected as cause
Slide 48 · Coccidioides has a different diagnostic tissue form
Histoplasma is recognized as small budding yeasts, often within phagocytes.
Coccidioides forms thick-walled tissue spherules containing small endospores.
Recognizing the fungal structure helps resolve otherwise similar granulomatous inflammation.
Histoplasma
Coccidioides
Spherule with endospores
Slide 49 · Blastomyces has thick walls and broad-based budding
Blastomyces tissue forms are larger round yeasts with thick double-contoured walls.
Broad-based budding contrasts with the thin-based budding of Histoplasma.
This is a tissue-form comparison, not a claim that all specimens are easily classified.
Histoplasma
Blastomyces
Broad-based bud
Slide 50 · The differential begins with pattern, then organism
Pattern of injury
Search for organism
Compare tissue form
Corroborating tests
Mechanistic interpretation
Start by recognizing granulomatous, necrotizing, or phagocyte-rich inflammation.
Examine the tissue for the type and intracellular distribution of fungal forms.
Use serologic, antigen, and culture studies when morphology is insufficient.
Slide 51 · Tissue biopsy can establish fungal identity
Fungal identification in tissue is a direct route to diagnosis.
An informative biopsy demonstrates the organism in an interpretable tissue context.
The tissue reaction and fungal forms should be reported separately.
Tissue + organism
Interpret with the full clinical and pathologic context
Slide 52 · Fungal antigens may be detected in serum or urine
Sample
Test target
Diagnostic role
Serum
Fungal antigen
Diagnostic evidence
Urine
Fungal antigen
Diagnostic evidence
Slide 53 · Antibody testing is another diagnostic route
Serologic assays for fungal antibodies are listed among diagnostic approaches.
Antibody detection is distinct from direct organism identification.
Interpretation depends on the clinical context and any additional corroborating findings.
Antibody ≠ antigen
Interpret with the full clinical and pathologic context
Slide 54 · Culture provides microbiologic evidence
Fungal culture is a recognized diagnostic method.
Culture and tissue microscopy address different kinds of evidence.
Culture can provide additional etiologic evidence when tissue morphology is equivocal.
Slide 55 · Diagnostic confidence integrates multiple evidence types
Exposure + presentation
Tissue reaction
Organism / antigen / antibody / culture
Integrated interpretation
Mechanistic interpretation
Clinical pattern and geographic exposure establish the pretest context.
Serology or antigen studies, culture, and tissue biopsy provide diagnostic evidence.
Avoid declaring histoplasmosis from an isolated, nonspecific granuloma.
Slide 56 · Sampling and interpretation follow the phenotype
Presentation
Relevant evidence described
Interpretive caution
Pulmonary nodule
Biopsy, tests as appropriate
Granuloma not specific
Disseminated syndrome
Tissue yeasts, blood monocytes, tests
Granuloma may be absent
Slide 57 · Absence of granulomas does not exclude dissemination
Organized granulomas are a feature of the competent host response.
Their absence is specifically described in fulminant immunosuppressed disease.
In that setting, look for yeast-containing mononuclear phagocytes.
Mononuclear phagocyte
Cell nucleus
Intracellular yeasts
Schematic — not a photomicrograph
Slide 58 · Most cases resolve; Progressive cases need treatment
Clinical / immunologic branches
Self-limited disease
Resolution
Residual fibrosis possible
Progressive / immunosuppressed
Antifungal therapy
Clinical monitoring needed
Slide 59 · The host–lesion relationship unifies the disease
Inhaled microconidia
Intracellular survival
Cell-mediated control?
Granulomas or dissemination
Mechanistic interpretation
An inhaled environmental fungus becomes a primarily intracellular infection.
A competent Th1–macrophage response yields containment and often necrotizing granulomas.
Poor cellular immune control permits yeast-filled phagocytes and disseminated disease.
Slide 60 · Case 1 — Solitary pulmonary nodule
Illustrative teaching case
An otherwise healthy adult has a small, persistent pulmonary opacity.
Biopsy shows a fibrotic focus with concentric calcification.
There is a history of residence in the Ohio River Valley.
What pathologic sequence can link this finding to prior histoplasmosis?
Slide 61 · Case 1 — Interpreting the residual lesion
Interpretation
Pulmonary Histoplasma granuloma can undergo necrosis and later fibrotic healing.
Concentric calcification can leave a laminated residual nodule.
The morphology supports prior infection; It does not prove current active disease.
Granuloma → necrosis → fibrosis → concentric calcification
Slide 62 · Case 2 — Apical chronic pulmonary symptoms
Illustrative teaching case
A patient develops persistent cough, fever, and night sweats.
Imaging identifies an apical pulmonary process.
Histology shows necrotizing granulomatous inflammation.
Why is the organism still unresolved at this stage?
Slide 63 · Case 2 — Why the granuloma is not enough
Interpretation
The symptoms, apical site, and granuloma pattern overlap with tuberculosis.
Coccidioidomycosis and other causes also enter the granuloma differential.
Identify fungal yeasts or obtain compatible microbiologic evidence before assigning the cause.
A morphologic response is not an etiologic diagnosis.
Slide 64 · Case 3 — Immunosuppression and systemic illness
Illustrative teaching case
An immunosuppressed individual presents with multisystem disease.
Biopsy lacks organized granulomas but shows numerous mononuclear phagocytes.
Small yeasts are visible within the phagocytes.
What host–pathogen mechanism best explains this pattern?
Slide 65 · Case 3 — Failure of cellular immune containment
Interpretation
Insufficient Th1-mediated macrophage activation allows intracellular fungal survival.
Dissemination yields tissue accumulations of yeast-filled mononuclear phagocytes.
Absence of granulomas is compatible with fulminant disseminated histoplasmosis.
Poor cell-mediated control → intracellular proliferation → dissemination
Slide 66 · Three high-yield discriminators
Exposure: Inhaled microconidia from environmentally contaminated dust.
Mechanism: Intraphagocytic survival until Th1, IFN-γ, and TNF-dependent control develops.
Morphology: Necrotizing granulomas in controlled lung disease versus yeast-laden phagocytes in dissemination.
Confirmation: Organisms in tissue, culture, or serologic / antigen evidence.
Slide 67 · Selected primary reference
Robbins, Cotran & Kumar: Pathologic Basis of Disease, 11th edition (2026), Chapter 8: Infectious Diseases.
Histoplasmosis and Fig. 8.48, printed pp. 353–354; nearby sections on fungal infections, blastomycosis, and coccidioidomycosis.
The diagrams are original explanatory schematics; they are not substitutes for authentic diagnostic histology.